Bone marrow-derived stem cell therapeutics developer BrainStorm Cell Therapeutics has announced plans to expand its R&D program to include the treatme

Source: Pharmaceutical Business Review
Posted: August 25, 2006

Summary:

Bone marrow-derived stem cell therapeutics developer BrainStorm Cell Therapeutics has announced plans to expand its R&D program to include the treatment of the effects of stroke.